After gains of 121.9% this afternoon, Regencell Bioscience shares are now trading at $22.99. Read below for the essential facts about this stock:
-
Its trailing earnings per share (EPS) is $-0.01, which brings its trailing Price to Earnings (P/E) ratio to -2299.0. The Health Care sector's average P/E ratio is 22.94
-
The company has a Price to Book (P/B) ratio of 1352.35 in contrast to the Health Care sector's average P/B ratio is 3.19
-
The current ratio is currently 41.9, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
The company's free cash flow for the last fiscal year was $-4007063 and the average free cash flow growth rate is -59.3%